Biologics before triple therapy not cost effective for rheumatoid arthritis
Tuesday, May 30, 2017 - 11:32
in Health & Medicine
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA), research concludes.